EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Platelet Glycoprotein Iib Iiia Inhibitors In Cardiovascular Disease Contemporary Cardiology 2nd Edition 2nd Edition A Michael Lincoff

SKU: BELL-2008382

Platelet Glycoprotein Iib Iiia Inhibitors In Cardiovascular Disease Contemporary Cardiology 2nd Edition 2nd Edition A Michael Lincoff

$ 31.00 ~~$ 45.00~~ (-31%)

0 reviews

Platelet Glycoprotein Iib Iiia Inhibitors In Cardiovascular Disease Contemporary Cardiology 2nd Edition 2nd Edition A Michael Lincoff instant download after payment.

Publisher: Humana

File Extension: PDF

File size: 3.68 MB

Pages: 440

Author: A. Michael Lincoff

ISBN: 9781588291851, 9781592593767, 1588291855, 1592593763

Language: English

Year: 2003

Edition: 2

Product desciption

Platelet Glycoprotein Iib Iiia Inhibitors In Cardiovascular Disease Contemporary Cardiology 2nd Edition 2nd Edition A Michael Lincoff by A. Michael Lincoff 9781588291851, 9781592593767, 1588291855, 1592593763 instant download after payment.

This substantially revised second edition contains new chapters on the role of GPIIb/IIIa blockade during acute coronary syndromes or with fibrinolytic therapy during acute myocardial infarctions, and updated and expanded information on the latest trials of GP IIb/IIIa inhibition during percutaneous coronary intervention. Additional improvements include a new chapter on outcomes with chronic oral GP IIb/IIIa blockade following acute coronary syndromes, discussion of GPIIb/IIIa blockade with other platelet and thrombin inhibitors, and a review of the potential effects beyond inhibition of platelet aggregation. Platelet Glycoprotein IIb/IIIa inhibitors in Cardiovascular Disease, Second Edition offers today's physicians, cardiologists, emergency room doctors, and basic scientists the most complete and authoritative review of the state-of-the-art in glycoprotein Iib/IIIa receptor inhibitor use.